Hot Penny Stocks | AimHighProfits Predicts A Superb 2013

2013 StampHappy New Year? You bet your ass it is. The Fiscal Cliff woes, like we have been telling everyone of our VIP members, was all a bunch of “fluff” that was doing nothing more but creating buying opportunities on big board stocks. The end of the world with the Mayan calendar predictions went up in flames just ike the Y2K bug and traders who didn’t pull out saw 6 ...

Continue Reading →
0

CXM | Cardium Therapeutics Is Way Too Good To Be $0.216

Scanning across a wide array of stocks under $1, we came across an AMEX listed penny stock, Cardium Therapeutics Inc. (CXM), which looked too good to pass on. It’s not just that Cardium is the leading Cardiovascular Gene Therapy company, but their recent acquisition of To Go Brands Inc. and lack of debt that made CXM ...

Continue Reading →
0

GCEI | Global Clean Energy Rises 162% Since Election Day

GCEI Stock, Global Clean Energy Inc.It’s been a week now since Obama was declared the winner of the 2012 elections and Global Clean Energy Inc. (GCEI) has been on a roll ever since. Trading volume was the highest its been since we re-introduced the waste-to-energy focused Company to our subscribers and the patience paid off. Since election day, GCEI stock has risen as ...

Continue Reading →
0

GCEI | Obama’s Win Great For Green Energy Companies

Green Energy Stocks, GCEI, GCEI StockFour more years! With Obama’s re-election, what many investors are already projecting is that government funds and tax-laden incentives will be robust for companies focused on clean, green energy alternatives. Exactly why penny stock traders should have Global Clean Energy Inc. (GCEI) on their radar screens for the coming week and months ahead. Some speculator’s who have been ...

Continue Reading →
0

GALE | Did You Already Buy Galena Biopharma? You Better

GALE Stock, Galena Biopharma Inc., Galena stock Thursday, October 25th, the penny stock of Galena Biopharma Inc. (GALE), already up 54.68% since our June 5th alert, received additional Wall Street coverage. Analysts at McNicoll Lewis & Vlak, MLV Capital, initiated coverage with a “buy” rating and a $6.00 price target on GALE stock — a 179% upside and $2 more per ...

Continue Reading →
0

LTS | Smart Money Flowing To Ladenburg Thalmann Financial

LTS Stock, Cheap Banking Stocks, Bank Stocks, Ladenburg Thalman StockTrading penny stocks can be tricky if you’re strapped for time to “flip and rip” during market hours which is why many investors look for companies they can go long on. Unless you see a total collapse of the financial system in the near future, consider NYSE MKT listed Ladenburg Thalmann Financial Services Inc. (LTS). The investment bank ...

Continue Reading →
0

AMPE | Hard Not To See Potential In Ampio Pharmaceuticals

AMPE stock, Ampio Pharmaceuticals, ZertaneShares of Ampio Pharmaceuticals Inc. (AMPE) are not having their best trading after analysts at Aegis set a “buy” rating and a $11.00 price target on the stock. Having seen $8.50 well back in October of last year, AMPE stock is not having the rally a biopharmaceutical company should have after being upgraded and agreeing with a ...

Continue Reading →
0

Hot Penny Stocks | APDN And ZERO Lead Monday As Predicted

Two of our penny stock picks, Applied DNA Sciences (APDN) and Save the World Air (ZERO) lead the OTC Monday just as we had predicted they would. APDN stock got its boost from SeeThruEquity, a leading investment research and corporate access firm focused on public smallcap and microcap companies, who listed the ...

Continue Reading →
0

Two Of Our Picks Lead The OTC Monday, Is GCEI Next?

Global Clean Energy, Inc. (GCEI) is at the forefront of global initiatives to reduce greenhouse gas emissions and lower the dependency in North America and Europe on imported oil and natural gas, having proprietary and innovative technologies for clean coal and renewable energy and international partners in business, university, consulting and engineering. Global Clean Energy’s focus is organic waste recovery with their two developed complementary technologies to ...

Continue Reading →
0

APPA | AP Pharma On Alert With Upcoming NDA Re-submission

APPA Stock, AP Pharma, APF530“Honey honey, how you thrill me, ah-hah, honey honey” has been the theme for investors who bought into A.P. Pharma Inc. (APPA) prior to January 1, 2012. Without the issuance of one “SOS” all year, APPA stock has steadily climbed from 0.23 making the JMP Securities  “outperform” rating and $3.00 price target issued in June look like a “Nina, Pretty ...

Continue Reading →
0
Page 1 of 29 12345...»